Compare · CMPI vs RAVN
CMPI vs RAVN
Side-by-side comparison of Checkmate Pharmaceuticals Inc. (CMPI) and Raven Industries, Inc. (RAVN): market cap, price performance, sector, and recent activity on the wire.
Summary
- CMPI operates in Consumer Durables, while RAVN operates in Capital Goods - the two are in different parts of the market.
- RAVN is the larger of the two at $2.08B, about 44.0x CMPI ($47.4M).
- Both have 1 recent analyst rating on file.
- Company
- Checkmate Pharmaceuticals Inc.
- Raven Industries, Inc.
- Price
- $10.49+0.00%
- $58.04+0.11%
- Market cap
- $47.4M
- $2.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- n/a
- News (4w)
- 0
- 0
- Recent ratings
- 1
- 1
Checkmate Pharmaceuticals Inc.
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. The company has strategic alliances with Merck KGaA and Pfizer. Checkmate Pharmaceuticals, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Raven Industries, Inc.
Raven Industries, Inc., a technology company, provides various products to customers in the industrial, agricultural, geo-membrane, construction, aerospace and defense, and commercial lighter-than-air markets worldwide. It operates through three segments: Applied Technology, Engineered Films, and Aerostar. The Applied Technology segment designs, manufactures, sells, and services precision agriculture products and information management tools that enable farmers to enhance farm yields. Its products include application controls, GPS-guidance steering systems, field computers, automatic boom controls, machine automation, information management tools, and injection systems, as well as Slingshot, a communications platform for its ag retailers, custom applicators, and enterprise farms; and services comprise high-speed in-field Internet connectivity and cloud-based data management. This segment sells its products to original equipment manufacturers and through aftermarket distribution partners. The Engineered Films segment produces plastic films and sheeting for geo-membrane, agricultural, construction, and industrial applications; and offers design-build and installation services for plastic films and sheeting. This segment sells its products directly to end-customers and through independent third-party distributors. The Aerostar segment offers high-altitude stratospheric platforms, technical services, and radar systems to provide research, communications, and situational awareness capabilities to governmental and commercial customers in the aerospace and defense, and commercial lighter-than-air markets. Raven Industries, Inc. was incorporated in 1956 and is headquartered in Sioux Falls, South Dakota.
Latest CMPI
- Axonis Therapeutics Announces $115 Million Series A Financing
- venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies
- SEC Form 15-12B filed by Checkmate Pharmaceuticals Inc.
- SEC Form SC 13G/A filed by Checkmate Pharmaceuticals Inc. (Amendment)
- SEC Form SC 13D/A filed by Checkmate Pharmaceuticals Inc. (Amendment)
- SEC Form SC 13D/A filed by Checkmate Pharmaceuticals Inc. (Amendment)
- SEC Form SC 13D filed by Checkmate Pharmaceuticals Inc.
- SEC Form EFFECT filed by Checkmate Pharmaceuticals Inc.
- Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers $2.5M Milestone Payment to XOMA
- SEC Form 25-NSE filed by Checkmate Pharmaceuticals Inc.
Latest RAVN
- SEC Form 15-12B filed by Raven Industries, Inc.
- Raven Industries, Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 4: Everist Thomas S gifted 24,869 shares and returned 6,000 shares to the company, closing all direct ownership in the company
- SEC Form 4 filed by Holloway Janet M
- SEC Form 4: Kirby Kevin T. returned 13,207 shares to the company, closing all direct ownership in the company
- SEC Form 4: Rykhus Daniel A gifted 24,000 shares and returned 242,460 shares to the company, closing all direct ownership in the company
- SEC Form 4: Magnuson Lee A returned 3,032 shares to the company, closing all direct ownership in the company
- SEC Form 4: Brazones Steven E returned 46,453 shares to the company, closing all direct ownership in the company
- SEC Form 4: Freesemann Nicole M returned 4,208 shares to the company, closing all direct ownership in the company
- SEC Form 4: Wickersham Scott W returned 24,375 shares to the company, closing all direct ownership in the company